McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” third quarter ...

Furthermore, Coldwell notes that McKesson’s practice of providing guidance and explanations has become more opaque, especially in relation to its Medical-Surgical and Prescription Technology ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

McKesson Corporation was the highest-scoring large cap on the most recent Magic Formula screen for Oct. 2024. Click here to ...

Shares of McKesson (MCK) are oversold. They are also at a potential support level. Stocks that are oversold and at support tend to rally. The best traders traders focus on key price levels and ...

McKesson (MCK) closed at $502.12 in the latest trading session, marking a +1.42% move from the prior day. This move outpaced the S&P 500's daily gain of 0.71%. On the other hand, the Dow registered a ...

not keeping up with the Medical sector's loss of 3.6% and the S&P 500's gain of 1.21%. The investment community will be paying close attention to the earnings performance of McKesson in its ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $612.00.

Baird downgraded medical distributor McKesson (NYSE:MCK) to neutral from outperform on Tuesday, calling the company's plans to conduct an investor event with the sell-side community "unusual." ...

McKesson Co. (NYSE:MCK – Get Free Report) has earned an average recommendation of “Moderate Buy” from the sixteen brokerages ...

McKesson Corporation (NYSE:MCK) shareholders might be concerned after seeing the share price drop 16% in the last quarter. But in stark contrast, the returns over the last half decade have ...